title: Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?
authors.affiliation: Department of Clinical Oncology, Faculty of Medicine, State Key Laboratory in Oncology in South China, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: tony@clo.cuhk.edu.hk.
authors.forename: Tony S K
authors.initials: TSK
authors.lastname: Mok
authors.affiliation: Department of Clinical Oncology, Faculty of Medicine, State Key Laboratory in Oncology in South China, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
authors.forename: Herbert H
authors.initials: HH
authors.lastname: Loong
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D058990:Molecular Targeted Therapy; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; D043823:Taxoids